You are viewing the site in preview mode
Skip to main content
| | |
Group A (n = 25)
|
Group B (n = 28)
|
Group C (n = 26)
|
P
|
|---|
|
GFAP
|
T1
|
328.68 ± 54.50
|
325.79 ± 55.82
|
336.58 ± 61.04
|
0.776
|
|
T2
|
399.16 ± 55.40*
|
360.93 ± 56.71a*
|
389.12 ± 57.32*
|
0.042
|
|
T3
|
459.24 ± 56.37*#
|
396.68 ± 55.78a*#
|
431.96 ± 71.44b*#
|
0.002
|
|
UCHL1
|
T1
|
422.60 ± 165.27
|
413.43 ± 172.77
|
434.58 ± 186.98
|
0.906
|
|
T2
|
828.16 ± 134.20*
|
661.96 ± 166.73a*
|
782.00 ± 177.36b*
|
0.001
|
|
T3
|
1223.00 ± 126.37*#
|
849.21 ± 175.51a*#
|
1068.50 ± 167.71ab*#
|
< 0.001
|
- Data are presented as the mean ± standard deviation (pg/mL)
- GFAP glial fibrillary acidic protein; UCHL1 ubiquitin carboxyl-terminal hydrolase isozyme L1
- aP<0.05 compared to Group A, bP<0.05 compared to Group B at the same point in time
- *P < 0.05, #P < 0.05 compared to T1 and T2 within each group
